Approval · Notice of Compliance 475 · 2003
AVODART: Notice of Compliance 475
Issued July 22, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 475
- Date
- July 22, 2003
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Type i and ii 5 alpha-reductase inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AVODART | 02247813 | Marketed |
Medicinal ingredients
- DUTASTERIDE 0.5 MG per CAP